They were 39 in 2013. Nowadays, private companies valued at over $1 billion — so-called "unicorn" companies — number more than 1,100 worldwide, with a whopping cumulative valuation of $3.8 trillion.
In Greater Boston, there's no shortage of tech and biotech companies hitting that milestone. In the past six months, a handful of mostly software firm joined the unicorn herd with valuations between $1 billion and $2 billion.
WATCH ANYTIME FOR FREE
 |
Stream NBC10 Boston news for free, 24/7, wherever you are. |
More on this story from Boston Business Journal
Get updates on what's happening in Boston to your inbox. Sign up for our News Headlines newsletter.
Copyright Boston Business Journal
